• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Peer Review Process
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
ALEXMED ePosters
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 7 (2025)
Volume Volume 6 (2024)
Volume Volume 5 (2023)
Volume Volume 4 (2022)
Volume Volume 3 (2021)
Issue Issue 4
Issue Issue 3
Issue Issue 2
Issue Issue 1
Volume Volume 2 (2020)
Volume Volume 1 (2019)
Abdulshafia, A. (2021). SERUM LEVELS OF ACTIVE COMPLEMENT C3 AND C4 IN PRE- ECLAMPTIC AND NORMOTENSIVE CASES AND THEIR CORRELATION TO FETAL AND MATERNAL OUTCOME. ALEXMED ePosters, 3(1), 20-21. doi: 10.21608/alexpo.2021.59733.1112
Asmaa Salih Abdulshafia. "SERUM LEVELS OF ACTIVE COMPLEMENT C3 AND C4 IN PRE- ECLAMPTIC AND NORMOTENSIVE CASES AND THEIR CORRELATION TO FETAL AND MATERNAL OUTCOME". ALEXMED ePosters, 3, 1, 2021, 20-21. doi: 10.21608/alexpo.2021.59733.1112
Abdulshafia, A. (2021). 'SERUM LEVELS OF ACTIVE COMPLEMENT C3 AND C4 IN PRE- ECLAMPTIC AND NORMOTENSIVE CASES AND THEIR CORRELATION TO FETAL AND MATERNAL OUTCOME', ALEXMED ePosters, 3(1), pp. 20-21. doi: 10.21608/alexpo.2021.59733.1112
Abdulshafia, A. SERUM LEVELS OF ACTIVE COMPLEMENT C3 AND C4 IN PRE- ECLAMPTIC AND NORMOTENSIVE CASES AND THEIR CORRELATION TO FETAL AND MATERNAL OUTCOME. ALEXMED ePosters, 2021; 3(1): 20-21. doi: 10.21608/alexpo.2021.59733.1112

SERUM LEVELS OF ACTIVE COMPLEMENT C3 AND C4 IN PRE- ECLAMPTIC AND NORMOTENSIVE CASES AND THEIR CORRELATION TO FETAL AND MATERNAL OUTCOME

Article 20, Volume 3, Issue 1, March 2021, Page 20-21  XML
Document Type: Preliminary preprint short reports of original research
DOI: 10.21608/alexpo.2021.59733.1112
View on SCiNiTO View on SCiNiTO
Author
Asmaa Salih Abdulshafia email
Faculty of omar almokhtar libya 2008
Abstract
Preeclampsia is a syndrome diagnosed by hypertension and proteinuria after 20 weeks of gestation; it affects 5–10% of all pregnancies and remains a leading cause of maternal and fetal morbidity and mortality. Based on clinical presentation, preeclampsia is considered as a late pregnancy disorder, but the molecular events leading to its onset seem to occur early in pregnancy. The early phase of the disease is characterized by suboptimal placentation and hemodynamic maladaptation to the pregnancy while at later stages generalized vascular dysfunction leading to clinical syndrome of preeclampsia, Maternal symptoms of preeclampsia are considered consequences of placental pathology associated with poor placental perfusion, inflammation and ischemia / hypoxia,trophoblast damageand activation of complement pathways either classical or alternative pathway.the activation of the complement system plays an important role both in maintaining normal pregnancy and in the pathogenesis of pre‐eclampsia, activation of both classical and alternative pathways plays an important role in cleaning up the numerous trophoblastic cell fragments formed during the placental establishment process. If the complement system is over activated, however, the activating complement component C3a and C4a can activate a maternal systemic inflammatory response, leading to the corresponding manifestations of pre‐eclampsia
Keywords
Complement c3; complement C4; preeclampsia
Supplementary Files
download 1112 Presentation5.pdf
Statistics
Article View: 224
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by NotionWave.